🇺🇸 FDA
Patent

US 8324192

Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

granted A61KA61K31/573A61K31/58

Quick answer

US patent 8324192 (Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract) held by The Regents of the University of California expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
50
CPC classes
A61K, A61K31/573, A61K31/58, A61K47/26, A61K9/0056